| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | 0.039 | 0.2 |
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | -0.21 | 0.2 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.037 | 0.2 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.2 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |